Cart
sales@molnova.com
Mafenide hydrochloride
CAS No. 138-37-4
Mafenide hydrochloride( Marfanil | Mafenide Hydrochloride )
Catalog No. M11591 CAS No. 138-37-4
Mafenide hydrochloride is a sulfonamide-type medication used as an antibiotic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 30 | In Stock |
|
| 50MG | 41 | In Stock |
|
| 100MG | 52 | In Stock |
|
| 200MG | 77 | In Stock |
|
| 500MG | 124 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMafenide hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionMafenide hydrochloride is a sulfonamide-type medication used as an antibiotic.
-
DescriptionMafenide hydrochloride is a sulfonamide-type medication used as an antibiotic.
-
In Vitro——
-
In Vivo——
-
SynonymsMarfanil | Mafenide Hydrochloride
-
PathwayMembrane Transporter/Ion Channel
-
TargetCarbonic Anhydrase
-
RecptorCarbonic anhydrase VI
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number138-37-4
-
Formula Weight222.69
-
Molecular FormulaC7H11ClN2O2S
-
Purity>98% (HPLC)
-
SolubilityWater: 10 mM
-
SMILESO=S(C1=CC=C(CN)C=C1)(N)=O.[H]Cl
-
Chemical Name4-(Aminomethyl)benzenesulfonamide hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Demirdag R, et al. Bioorg Med Chem. 2013 Mar 15;21(6):1522-5.
molnova catalog
related products
-
hCAI/II-IN-6
hCAI/II-IN-6 is a selective and orally active inhibitor of human carbonic anhydrase (CA). hCAI/II-IN-6 inhibited hCA I, hCA II, hCA VII, and hCA XII with Ki values of 220, 4.9, 6.5, and ＞50,000 nM.
-
Girentuximab
Girentuximab (G250) is a potent anti-carbonic anhydrase IX (CAIX) monoclonal antibody with anticancer activity for the study of uroepithelial carcinoma PET (ZiPUP).
-
Levosimendan
Levosimendan is a calcium sensitizer acting through calcium-dependent binding to cardiac troponin C (cTnC), provides treatment for heart failure.
